Original Research
Accepted on 30 Sep 2025
Circulating Free DNA as a Predictive Biomarker for Response to Nivolumab and Platinum-Based Chemotherapy in Metastatic Esophageal Adenocarcinoma: A Prospective Pilot Study
in Gastrointestinal Cancers: Gastric and Esophageal Cancers